Delivery Order SPE2DB24D2100-SPE2DB24FBCGD
Award Date
7/2/24
Potential Completion Date
7/3/24
Potential Value
$19K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,122.55 firm fixed-price delivery order is for the supply of QNASL 80 MCG NASAL SPRAY 10.6GM, a pharmaceutical product. The contract has an ultimate completion date of March 28, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of a pharmaceutical product - QNASL 80 MCG NASAL SPRAY 10.6GM. The contract, valued at $2,055.12, is a firm fixed-price delivery order with a completion date of November 12, 2024. The award does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,349.47, is a delivery order for the supply of QNASL 80 MCG NASAL SPRAY 10.6GM, a specialty medication. The contract has an ultimate completion date of November 19, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply QNASL 80 MCG NASAL SPRAY 10.6GM. This $4,163.41 award is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 that allows AmerisourceBergen to provide pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The contract has no set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of QNASL 80 MCG NASAL SPRAY 10.6GM. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $3,455.04 and a completion date of October 11, 2024. This award is not a set-aside contract. Amerisourcebergen Drug Corp's Corporate Office Division is the prime contractor for this delivery order, which is...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,653.62 firm-fixed-price contract provides for the supply of QNASL 80 MCG NASAL SPRAY 10.6GM, a prescription medication. The contract has an ultimate completion date of December 18, 2024. This appears to be a direct award to AmerisourceBergen, as no set-aside designation is mentioned. The company holds a significant $999,999,999 Indefinite...
This is a $1,322.09 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of QNASL 80 MCG nasal spray. The contract has an ultimate completion date of June 4, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive...
This federal contract award is for the delivery of QNASL 80 MCG NASAL SPRAY 10.6GM to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract was awarded to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to federal agencies, particularly the Department of Defense (DoD) and Veterans Affairs (VA). The contract is a Delivery Order with a Firm Fixed Price of $1,555.76 and an ultimate completion date of April 30, 2024....
This federal contract award, with ID SPE2DB20D2104|SPE2DB25FMMDW, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,524.25 firm-fixed-price delivery order is for the supply of QNASL 80 MCG NASAL SPRAY 10.6GM to support military healthcare programs. The contract has an ultimate completion date of March 31, 2025 and was awarded on March 28, 2025. There is no set-aside designation for this...
This federal contract award is for the delivery of QNASL 80 MCG NASAL SPRAY 10.6GM to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $1,113.03 and was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price and has an ultimate completion date of May 22, 2024. There is no set-aside designation for this award. Amerisourcebergen Drug Corp holds...